Hannah Bower
9PUBLICATIONS
15CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Dec 27, 2023
Are JAKis more effective among elderly patients with RA, smokers and those with higher cardiovascular risk? A comparative effectiveness study of b/tsDMARDs in Sweden.Hannah Bower, Thomas Frisell, Daniela di Giuseppe
|Nov 23, 2023
Comparative cardiovascular safety with janus kinase inhibitors and biological disease-modifying antirheumatic drugs as used in clinical practice: an observational cohort study from Sweden in patients with rheumatoid arthritis.Hannah Bower, Thomas Frisell, Daniela di Giuseppe
|Mar 03, 2023
Cancer risks with JAKi and biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis or psoriatic arthritis: a national real-world cohort study.Viking Huss, Hannah Bower, Karin Hellgren
|Feb 14, 2023
Safety of biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis as used in clinical practice: results from the ARTIS programme.Thomas Frisell, Hannah Bower, Matilda Morin
|Sep 23, 2022
Venous thromboembolism with JAK inhibitors and other immune-modulatory drugs: a Swedish comparative safety study among patients with rheumatoid arthritis.Viktor Molander, Hannah Bower, Thomas Frisell
|Jan 13, 2022
Validation and characterization of venous thromboembolism diagnoses in the Swedish National Patient Register among patients with rheumatoid arthritis.V Molander, H Bower, J Askling
Pageof 2
Frequent Collaborators
8 joint publications
Johan Askling
6 joint publications
Thomas Frisell
5 joint publications
Bénédicte Delcoigne
4 joint publications
Ulf Lindström
3 joint publications
Daniela Di Giuseppe
2 joint publications
Viktor Molander
2 joint publications
Katerina Chatzidionysiou
2 joint publications
Carl Turesson
2 joint publications
Christopher Sjowall
2 joint publications
Helena Forsblad-d'Elia
